The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19

The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19

Objective: During the COVID-19 pandemic the continuation or cessation of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARBs) has been contentious. Mechanisms have been proposed for both beneficial and detrimental effects. Recent studies have focused on mortality...

Full description

Bibliographic Details
Main Authors: Philip Braude, Ben Carter, Roxanna Short, Arturo Vilches-Moraga, Alessia Verduri, Lyndsay Pearce, Angeline Price, Terence J. Quinn, Michael Stechman, Jemima Collins, Eilidh Bruce, Alice Einarsson, Frances Rickard, Emma Mitchell, Mark Holloway, James Hesford, Fenella Barlow-Pay, Enrico Clini, Phyo Kyaw Myint, Susan Moug, Kathryn McCarthy, Jonathan Hewitt
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:International Journal of Cardiology: Heart & Vasculature
Subjects:
Coronavirus
Angiotensin receptor antagonists
Angiotensin-converting enzyme inhibitors
Hospitalization
Hospital mortality
Online Access:http://www.sciencedirect.com/science/article/pii/S2352906720303584

Internet

http://www.sciencedirect.com/science/article/pii/S2352906720303584

Similar Items